跳至主要内容
临床试验/NCT01005303
NCT01005303已完成2 期

A Trial of Micronutrient Supplementation in Patients With Heart Failure

Belfast Health and Social Care Trust1 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2009年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
79
试验地点
1
主要终点
Left Ventricular Ejection Fraction

研究概览

简要总结

There is some evidence to suggest that patients with heart failure may have a reduced dietary intake of vitamins and essential minerals (micronutrients) and that this may worsen the function of the heart. This study is designed to investigate if supplementation with micronutrients (including high-dose vitamin D) will improve the function of the heart in patients with heart failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • New York Heart Association Class II and III
  • Already on or tried on best known medical treatment (ACE inhibitor and beta-blocker)
  • Stable for a period of at least 6 weeks
  • Left ventricular ejection fraction less than or equal to 45%

排除标准

  • History of significant alcohol ingestion (more than 40 units per week)
  • Severe renal dysfunction (GFR less than 30ml/min)
  • Severe hepatic dysfunction (known liver disease or transaminases greater than 3 times the upper limit of normal)
  • Atrial fibrillation (in the absence of a pacemaker)
  • Frequent ventricular ectopics
  • On waiting list for cardiac transplantation
  • Uncontrolled diabetes mellitus
  • Inability to give informed consent
  • Estimated life span less than 12 months
  • Already taking a multivitamin/mineral supplement
  • Already taking a vitamin-D containing fish oil
  • Woman of child-bearing potential
  • History of renal stones, hypercalcaemia, sarcoidosis, haemochromatosis or lactose intolerance

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

Micronutrient

Active Comparator

干预措施: Forceval plus 50 micrograms Vitamin D3 (Drug)

结局指标

主要结局

Left Ventricular Ejection Fraction

时间窗: Baseline, and 12 months

次要结局

  • Serum Interleukin-6 (IL-6) Concentration(Baseline, and 12 months)
  • Serum C-reactive Protein (CRP) Concentration(Baseline, and 12 months)
  • Serum Tumor Necrosis Factor-alpha (TNF-α) Concentration(Baseline, and 12 months)
  • Serum Interleukin-10 (IL-10) Concentration(Baseline, and 12 months)
  • Six Minute Walk Test Distance(Baseline, and 12 months)
  • Quality of Life Questionnaire Score(Baseline, and 12 months)
  • Serum N-terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) Concentration(Baseline, and 12 months)
  • Urinary 8-iso-prostaglandin F2 Alpha (8-iso-PGF2α) Concentration(Baseline, and 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pascal McKeown

Principal Investigator

Belfast Health and Social Care Trust

研究点 (1)

Loading locations...

相似试验